January 22, 2019
A unit of Valeant Pharmaceuticals can keep its false drug marketing claims against a subsidiary of rival Virtus Pharmaceuticals in California federal court, a judge has ruled, finding the dispute didn't have to go through the U.S. Food and Drug Administration first.
October 25, 2018
A California federal judge said Thursday he'll likely allow Valeant to proceed with lawsuits alleging two pharmaceutical companies falsely advertised U.S. Food and Drug Administration approval of copycat versions of its irritable bowel syndrome drug, saying he didn't buy arguments that potential appeals to the FDA preempted the suits.